Andere Sprachen Calliditas Therapeutics AB

Aktien

A2JP36

SE0010441584

CALTX

Realtime-Estimate Cboe Europe Andere Börsenplätze 17:25:00 14.05.2024			% 5 Tage	% 1. Jan.
122,9 ^SEK	+6,59 %		+9,03 %	-4,09 %

17:10	Europäische Aktien werden in den USA als American Depositary Receipts gehandelt und steigen am Dienstag leicht an	MT
16:47	Calliditas Therapeutics Partner bietet Nefecon in China an; Aktien steigen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	17:10
Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise	16:47
Calliditas' Partner Everest Medicines Starts Commercial Launch of Nefecon in China	13:01
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08.05.
Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints	06.05.
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib	06.05.
Calliditas Therapeutics AB Announces Positive Topline Results of Phase 2 Head and Neck Cancer Trial with Lead NOX Inhibitor Candidate, Setanaxib	06.05.
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	02.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25.04.
Calliditas Therapeutics' 2023 Annual Report Published	24.04.
Calliditas Therapeutics Says OLE Study Shows Treatment Response Consistent With Late-Stage NefIgArd Study's Findings	24.04.
Calliditas Announces Positive NefIgArd Open Label Extension Results	24.04.
Calliditas Therapeutics AB Announces Positive NefIgArd Open Label Extension Results	24.04.
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading	22.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19.04.
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024	18.04.
Calliditas Therapeutics AB Presents Additional Data Analyses from the Phase 3 NeflgArd Trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024	18.04.
Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024	18.04.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	17.04.
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading	15.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Calliditas Therapeutics AB

Aktien

A2JP36

SE0010441584

CALTX

Andere Sprachen

Filter